Get Breaking Alerts on Stocks Before The Mainstream Media

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We guarantee you to keep your privacy
Connect with us
Financial Press
:-pfizer-biontech-vaccine-could-be-approved-‘within-days,’-with-uk.-set-to-be-first-to-start-covid-19-shots
:-pfizer-biontech-vaccine-could-be-approved-‘within-days,’-with-uk.-set-to-be-first-to-start-covid-19-shots

Breaking

: Pfizer-BioNTech vaccine could be approved ‘within days,’ with U.K. set to be first to start COVID-19 shots

The U.K. is set to become the first country in the world to approve a COVID-19 vaccine, with the country’s medical regulator likely to give approval “within days,” according to media reports.

The experimental vaccine being developed by drugmaker Pfizer
PFE,
+1.91%

and its partner BioNTech
BNTX,
+4.79%

could be delivered hours after receiving approval from the Medicines and Healthcare products Regulatory Agency, said a report in the Financial Times, quoting government officials.

The first jabs could take place from Dec. 7, the FT said. Its report was later confirmed by Bloomberg, which cited a person familiar with the situation.

The U.K. has ordered 40 million doses of the Pfizer-BioNTech vaccine, which was shown to have an efficacy rate of 95% in people over 65 years in a Phase 3 trial.

The MHRA declined to comment on the reports, but reiterated its Nov. 23 statement that said a decision on whether to approve the Pfizer-BioNTech coronavirus vaccine will be made in the “shortest time possible,” after receiving further data on the shot.

Read: Decision on approving Pfizer-BioNTech vaccine to be made in ‘shortest time possible,’ U.K. regulator says

Meanwhile, the U.S. Food and Drug Administration has said it would meet on Dec. 10 to discuss whether to authorize use of the Pfizer-BioNTech vaccine.

On Sunday, the U.K.’s Department of Health said it had increased its order for a vaccine developed by U.S. biotech Moderna
MRNA,
+16.34%

from 5 million to 7 million doses, enough for 3.5 million people. Moderna’s experimental shot has shown to be 95% effective in Phase 3 trials. It has said it would apply for regulatory approval in the U.S. in the coming weeks.

The U.K. has now secured access to a total of 357 million doses of vaccines from seven different developers. This includes 100 million doses of the vaccine being developed by drugmaker AstraZeneca
AZN,
+0.01%

and the University of Oxford.

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure 🙂

“With a wide range of vaccine candidates in our portfolio, we stand ready to deploy a vaccine should they receive approval from our medicines regulator, starting with those who will benefit most,” said health secretary Matt Hancock.

Read: U.K. Pushes for AstraZeneca Vaccine Approval Amid Questions Over Trial Data

The government on Saturday appointed Conservative lawmaker Nadhim Zahawi as a new health minister to oversee rollout of the COVID vaccine in England. The government has said that frontline health-care workers and nursing-home residents will be the first to be vaccinated, followed by older people, starting with those over 80.

Hopes of an imminent vaccine rollout come as the number of coronavirus cases in England fell by a third after the rollout of lockdown measures in November, according to a new study by Imperial College London and Ipsos Mori.

The React-1 Study, published on Monday, was based on swabbing 105,000 people between Nov. 13 and 24.

The findings showed that an estimated 0.96% of England’s population has the virus, or around 1 in 100 people. That is roughly a 30% drop in the number of infections compared with previous findings, where more than one in 80, or 1.3% of people, had the virus as of Nov. 2.

The R number is now 0.88, meaning that the country’s epidemic is currently shrinking rather than growing. The R rate is the average number of secondary infections produced by a single infected person. It needs to drop below one to curtail the number of infections.

Downward trends were seen across the majority of the country, including in previous hot spots in the north, and most age groups except those of school age, where there has been an increase, the report said.

The study also found that virus infections were halving every 37 days.

The results highlight the uneven impact of the virus, with health workers, people living in large households, and minority-ethnic individuals having a higher risk of infection.

Read: People of Black and Asian descent up to twice as likely to get COVID as white people: meta-analysis

Prof. Paul Elliott, the director of the program at Imperial College who led the study, said the data offered “encouraging signs” for England’s epidemic, which had seen a fall in infections at the national level and in particular across regions that were previously worst affected.

“These trends suggest that the tiered approach helped to curb infections in [the worst-affected areas] and that lockdown has added to this effect,” Elliot said, but warned that “as we approach a challenging time of year, it’s even more vital that through our actions and behaviors we all play our part in helping to keep the virus at bay.”

Hancock also welcomed the study’s findings, but said it was too soon to “take our foot off the pedal.”

Read: Boris Johnson says 3-tiered restrictions to return after England’s lockdown ends Dec. 2

The findings from the React-1 study come as Prime Minister Boris Johnson is facing growing opposition from some of his Conservative Party lawmakers for a plan to impose tough restrictions across most of England when the national lockdown ends on Dec. 2.

The new measures will see regions placed in one of three tiers: medium, high, and very high. Lawmakers will vote on the new proposals on Tuesday. Johnson on Saturday pledged to offer them a second vote on the tier system on Feb. 3, 2021, in a bid to appease those lawmakers who aren’t government ministers.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Breaking

Last Updated: Jan. 22, 2021 at 6:41 p.m. ET First Published: Jan. 22, 2021 at 3:46 p.m. ET Much of the channel’s sports programming...

Breaking

Earnings Outlook Published: Jan. 22, 2021 at 6:26 p.m. ET Company has shaken up its film strategy with HBO Max and participated in a...

Breaking

Last Updated: Jan. 22, 2021 at 6:21 p.m. ET First Published: Jan. 22, 2021 at 11:44 a.m. ET In recent weeks, Japan has declared...

Breaking

Earnings Outlook Published: Jan. 22, 2021 at 6:08 p.m. ET Investors’ gusto, which led to 33% gain in 2020, rooted in advertising from more...

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure :)

Get Breaking Stock Alerts

Email address

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address